LianBio presents EXPLORER-CN topline data and mavacamten China opportunity at virtual event

LianBio

Virtual investor event held May 1, 2023 to discuss EXPLORER-CN topline data for mavacamten.
Slide presentation furnished as Exhibit 99.1 covers China market opportunity pending regulatory approval.
No specific numeric topline results (e.g., efficacy, safety) included in the filing text provided.
Event intended to provide overview of mavacamten's commercial potential in China.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.